Mr perfusion imaging for gliomas

J Lee, MM Chen, HL Liu, FE Ucisik… - Magnetic …, 2024 - mri.theclinics.com
Although central nervous system (CNS) tumors constitute only 1% of cancers, they are one
of the leading causes of cancer deaths in young adults. 1 Nearly 30% of all brain tumors are …

[HTML][HTML] Implementation and evaluation of a dynamic contrast-enhanced MR perfusion protocol for glioblastoma using a 0.35 T MRI-Linac system

D Maziero, GA Azzam, M de La Fuente, R Stoyanova… - Physica Medica, 2024 - Elsevier
Purpose MRI-linear accelerator (MRI-Linac) systems allow for daily tracking of MRI changes
during radiotherapy (RT). Since one common MRI-Linac operates at 0.35 T, there are efforts …

[HTML][HTML] Time optimization of gadobutrol-enhanced brain MRI for metastases and primary tumors using a dynamic contrast-enhanced imaging

J Seo, C Lim, KY Lee, YC Koh, WJ Moon - BMC Medical Imaging, 2022 - Springer
Background Recent advances in rapid imaging techniques necessitate the reconsideration
of the optimal imaging delay time for contrast-enhanced T1-weighted imaging. The aim of …

[HTML][HTML] The TRUTH confirmed: validation of an intraindividual comparison of gadobutrol and gadoteridol for imaging of glioblastoma using quantitative enhancement …

MJ Kuhn, JW Patriarche, D Patriarche… - European Radiology …, 2021 - Springer
Background Previous intraindividual comparative studies evaluating gadobutrol and
gadoteridol for contrast-enhanced magnetic resonance imaging (MRI) of brain tumours have …

[PDF][PDF] Optimal MRI time determination for intracerebral metastases and primary brain tumors after injecting a standard gadobutrol dose: Evidence from a dynamic …

J Seo, C Lim, KY Lee, YC Koh, WJ Moon - 2022 - scholar.archive.org
Background: Recent advances in rapid imaging techniques necessitate the reconsideration
of the optimal imaging delay time for contrast-enhanced T1-weighted imaging. The aim of …